Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Qiang Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3530-9855; OpenAlex author ID A5006890585. Sources: OpenAlex.

Their work

Papers
7 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2021: 1 paper · 2022: 4 papers · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 7

  1. Drug-associated pancreatic cancer: insights from real-world pharmacovigilance and network pharmacology. First author DOI 10.1080/14740338.2025.2469273↗
  2. Robotic Versus Laparoscopic Pancreaticoduodenectomy for Pancreatic Cancer: Evaluation and Analysis of Surgical Efficacy. Co-author DOI 10.1245/s10434-024-15764-1↗
  3. Construction of immune-related signature and identification of S100A14 determining immune-suppressive microenvironment in pancreatic cancer. Co-author DOI 10.1186/s12885-022-09927-0↗
  4. Construction of a novel model based on cell-in-cell-related genes and validation of KRT7 as a biomarker for predicting survival and immune microenvironment in … Co-author DOI 10.1186/s12885-022-09983-6↗
  5. Prognostic value of glycolysis markers in pancreatic cancer: A systematic review and meta-analysis. Last author DOI 10.3389/fonc.2022.1004850↗
  6. Management of Advanced Pancreatic Cancer through Stromal Depletion and Immune Modulation. Co-author DOI 10.3390/medicina58091298↗
  7. [Expression and Prognostic Value of Cripto-1 in Pancreatic Cancer]. First author DOI 10.3881/j.issn.1000-503x.12734↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jianlu Song · 3 shared papers, 2022 · strength 0.50
  2. Rexiati Ruze · 3 shared papers, 2022 · strength 0.50
  3. Ruiyuan Xu · 3 shared papers, 2022 · strength 0.50
  4. Xinpeng Yin · 3 shared papers, 2022 · strength 0.50
  5. Hao Xie · 1 shared paper, 2026 · strength 0.43
  6. Wenming Wu · 1 shared paper, 2026 · strength 0.43
  7. Chengcheng Wang · 2 shared papers, 2022 · strength 0.34
  8. Yuan Chen · 2 shared papers, 2022 · strength 0.33
  9. Yupei Zhao · 2 shared papers, 2022 · strength 0.33
  10. Tiantong Liu · 1 shared paper, 2022 · strength 0.22
  11. Sihang Cheng · 1 shared paper, 2022 · strength 0.22
  12. Zhiwei Peter Wang · 1 shared paper, 2022 · strength 0.22
  13. Ming Cui · 1 shared paper, 2024 · strength 0.21
  14. Shuai Yuan · 1 shared paper, 2024 · strength 0.21
  15. Lixin Chen · 1 shared paper, 2024 · strength 0.21
  16. Menghua Dai · 1 shared paper, 2024 · strength 0.21
  17. Chengcheng Wang · 1 shared paper, 2022 · strength 0.16
  18. Xiang Gao · 1 shared paper, 2021 · strength 0.16
  19. Boju Pan · 1 shared paper, 2021 · strength 0.16
  20. Quan Liao · 1 shared paper, 2021 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.